Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline
Strong Bullish
100.0
Morgan Stanley's price target implies that shares of Johnson & Johnson could rise another 17%.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.